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INTRODUCTIONVenous leg ulcers (VLUs) have afﬂicted mankind since operative approach used the techniques of great saphenous
recorded history. Although Hippocrates described the rela-
tionship between VLUs and varicose veins, he theorized
that VLUs were necessary to permit harmful “humours”
to egress from the body.1 Thus, if a VLU healed, it should
be reopened. In De ulceribus, Hippocrates advised against
prolonged standing and against moisturizing the ulcer
(only with wine).1 Galen continued this concept that a
VLU was a site to rid the body of bile entrapment, which
could lead to madness. Fifteen hundred years after Hippo-
crates, the famous Arabic physician, Ibn Sina (Latin name
Avicenna, 980-1037) continued to advocate the Hippo-
cratic/Galen concept of reopening a VLU.1
VLU has affected the course of history and has been
associated with royalty. The noted French military surgeon,
Ambroise Pare (1510-1590), under the threat of having his
throat slit, healed the long-standing leg ulcer of Lord Van-
deville, Governor of Gravelline, with debridement, and
compression: “Roule the leg beginning at the foote and
ﬁnishing at the knee, not forgetting a little bolster about
the varicous veine.”1 Atypically for a surgeon, he famously
stated, “I dressed the wound, God healed it.”
After being crushed by a horse in a jousting competi-
tion, King Henry VIII (1491-1447) developed recurrent
VLUs. The etiology was most likely post-thrombotic in na-
ture secondary to his leg injury, although he was known to
have varicose veins. The pain and purulence with intermit-
tent sepsis allegedly inﬂuenced his judgment on state and
personal matters.2
Richard Wiseman, a surgeon to King Charles II, for
which loyalty to the king he nearly paid the price of death
in 1652 at Cromwell’s “High Court of Justice” at West-
minster, recognized the importance of compression to
heal a venous ulcer in his book Severall Chirugicall Trea-
tises and devised a laced leather stocking to achieve this
compression.1 Treatment of VLUs continued to be
nonsurgical, so that the development of a paste noncompli-
ant bandage by Unna in 1854 made VLU care more
convenient for patient and physician.1
In his series of Lettsomian lectures (1866) John Gay
clearly recognized that the etiology of VLU could be
related to varicose veins or to post-thrombotic injury to
the veins and preferred the term “venous” rather than vari-
cose ulcers.3
The Boston surgeon, John Homans, of the then Peter
Bent Brigham Hospital, recognized the need to surgically
reduce venous hypertension in patients with VLUs.3 HisAuthor conﬂict of interest: none.
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added removal of branch veins and incompetent perfo-
rating veins to the surgical strategy (the modern approach):“in surface varix complicated by varicosity of the perfo-
rating veins not only must the great saphenous be eradicated
but many of its branches in the calf must be followed and
excised in the search for incompetent perforating channels.”This is eerily similar to one of the recommendations in
the current guidelines. Linton, Cockett, and others to the
present day would modify this approach, but the initial
concept was that of Homans.3
In current times, VLUs have a major socioeconomic ef-
fect that is related to several factors: (1) their prevalence,
which ranges between 0.06% and 2%; (2) their common
occurrence, representing up to 80% of all leg ulcers; and
(3) their predilection for recurrence of 50% to 70% within
6 months.4 As a result, the current direct cost of treatment
for VLUs in the United States amounts to $10,000 to
$12,000 per year per patient and a comparable ﬁgure in
Germany. Thus, the direct expenditures for treatment of
VLU may amount to 1% of the health care budgets for
some European countries.4 The indirect costs are also signiﬁ-
cant due to the lost productivity fromwork for the patient and
the family members taking care of him or her, out-of-pocket
expenses (copays), transportation, and premature disability.
Guidelines should develop best practices to achieve
the best health outcomes for the most reasonable health
care dollar.4 The treatment of VLUs uniquely involves
all health care providersdprimary care physicians, sur-
geons, dermatologists, wound care specialists, dermatolo-
gists, and podiatry and care that relies on nursing and
physical therapists.
The current guideline is the direct result of an Amer-
ican Venous Forum (AVF)-sponsored initiative “to reduce
the incidence of VLU by 50% over the next decade.”5
A number of strategies were formulated at the Sixth Paciﬁc
Vascular Conference to achieve that goal, and guideline
development was a major component of a multipronged
approach to reduce the incidence of VLU.5 The AVF
Venous Ulcer Committee formed at that conference
responded to a request for proposal from the Society for
Vascular Surgery (SVS) Guidelines Committee. The cur-
rent VLU guideline represents a joint sponsored effort be-
tween the SVS and AVF and includes input from experts
representing different specialties interested in care of
VLUs. We are appreciative of the review and subsequent
endorsement of these guidelines by the American College
of Phlebology (ACP) and the Union Internationale de
Phlébologie (UIP) in an effort to make this an intersocietal
document. Both the ACP and the UIP submitted com-
ments on the document to which we responded.1S
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lines for the treatment of VLUs, they have predominantly
focused on wound care and compression. A previous sys-
tematic review of 14 VLU guidelines identiﬁed speciﬁc
areas or knowledge gaps that needed to be addressed:
role of advanced dressings; skin grafts, both autologous
and human skin equivalents; role of physical therapy for
improving ankle mobility to improve the calf-muscle
pump; role of iliac obstruction and treatment with stenting;
when and if to treat incompetent perforators; and preven-
tion of progression from CEAP C4 to C6.
4
Furthermore, during the last several years, new forms
of compression, advanced wound dressings, and minimally
invasive techniques with lower morbidity have been devel-
oped. There has also been an increasing recognition of
obstruction in the pathophysiology of VLUs, which re-
quires a different treatment path.
Currently, the management of VLUs too often has been
a siloed approach that focuses on the individual outcomes of
ulcer healing and ulcer recurrence, with little integration of
the two. What is important to the patient, however, is how
quickly a VLU heals and how long it remains healed, which
is best described in “ulcer-free days.” Strategies for the pre-
vention of the progression of chronic venous insufﬁciency
from “pre-ulcer stages” CEAP C4 to C6 need to be adopted
to avoid focusing on the disease state only when it has devel-
oped. This current guideline will attempt to critically eval-
uate, validate, and transfer such new techniques through
evidence-based reviews. The overall structure of the current
guidelines focuses on six major areas:
d Diagnosis
d Compression
d Wound Care
d Surgery/Endovascular
d Ancillary
d Prevention
All of these areas underwent a fresh review of the avail-
able literature by the respective team for that section,whereas Compression and Surgery/Endovascular treat-
ment received special attention with a formal systematic re-
view by Hassan Murad and his Mayo Clinic’s Knowledge
and Evaluation Unit, Rochester, Minn. These important
systematic reviews and meta-analysis accompanies the
guidelines as an integral part of this supplement.
The format of these guidelines is similar to the
guideline document, The care of patients with varicose
veins and associated chronic venous diseases: clinical prac-
tice guidelines of the Society for Vascular Surgery and the
American Venous Forum,6 but differs by focusing specif-
ically on VLUs. The overall summary of recommenda-
tions is presented at the beginning of the document,
and each guideline is individually presented with the
supporting evidence discussed for that recommenda-
tion. In these respects, we hope the current Evidence
based clinical practice guidelines of the Society for
Vascular Surgery (SVS) and the American Venous Forum
(AVF): Management of venous leg ulcers represents an
important step forward in coordinated care for patients
with VLUs.
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